Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Fitch

Showing results (61-70 of 67) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 67 results.
Transfusion|July 14, 2006
Antithrombin reduces monocyte and neutrophil CD11b up regulation in addition to blocking platelet activation during extracorporeal circulationChristine S Rinder, Henry M Rinder, Michael J Smith, et al.
JAMA Pediatrics|February 6, 2013
The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trialAaron S Kelly, Kyle D Rudser, Brandon M Nathan, et al.
Journal of Cardiac Surgery|January 28, 2005
Pharmacologic C5-complement suppression reduces blood loss during on-pump cardiac surgeryJohn C Chen, Scott A Rollins, Stanton K Shernan, et al.
Chest|June 8, 2021
Pleural Pressure Targeted Positive Airway Pressure Improves Cardiopulmonary Function in Spontaneously Breathing Patients With ObesityGaetano Florio, Roberta Ribeiro De Santis Santiago, Jacopo Fumagalli, et al.
Anesthesia and Analgesia|January 29, 2002
Transesophageal echocardiography interpretation: a comparative analysis between cardiac anesthesiologists and primary echocardiographersJoseph P Mathew, Manuel L Fontes, Susan Garwood, et al.
Obesity (Silver Spring, Md.)|November 15, 2011
Exenatide as a weight-loss therapy in extreme pediatric obesity: a randomized, controlled pilot studyAaron S Kelly, Andrea M Metzig, Kyle D Rudser, et al.
The Annals of Thoracic Surgery|March 3, 2004
Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypassStanton K Shernan, Jane C K Fitch, Nancy A Nussmeier, et al.
Pageof 7

Showing results (61-70 of 67) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 67 results.
Transfusion|July 14, 2006
Antithrombin reduces monocyte and neutrophil CD11b up regulation in addition to blocking platelet activation during extracorporeal circulationChristine S Rinder, Henry M Rinder, Michael J Smith, et al.
JAMA Pediatrics|February 6, 2013
The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trialAaron S Kelly, Kyle D Rudser, Brandon M Nathan, et al.
Journal of Cardiac Surgery|January 28, 2005
Pharmacologic C5-complement suppression reduces blood loss during on-pump cardiac surgeryJohn C Chen, Scott A Rollins, Stanton K Shernan, et al.
Chest|June 8, 2021
Pleural Pressure Targeted Positive Airway Pressure Improves Cardiopulmonary Function in Spontaneously Breathing Patients With ObesityGaetano Florio, Roberta Ribeiro De Santis Santiago, Jacopo Fumagalli, et al.
Anesthesia and Analgesia|January 29, 2002
Transesophageal echocardiography interpretation: a comparative analysis between cardiac anesthesiologists and primary echocardiographersJoseph P Mathew, Manuel L Fontes, Susan Garwood, et al.
Obesity (Silver Spring, Md.)|November 15, 2011
Exenatide as a weight-loss therapy in extreme pediatric obesity: a randomized, controlled pilot studyAaron S Kelly, Andrea M Metzig, Kyle D Rudser, et al.
The Annals of Thoracic Surgery|March 3, 2004
Impact of pexelizumab, an anti-C5 complement antibody, on total mortality and adverse cardiovascular outcomes in cardiac surgical patients undergoing cardiopulmonary bypassStanton K Shernan, Jane C K Fitch, Nancy A Nussmeier, et al.
Pageof 7